1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Steven Kiel
Steven Kiel
Articles (136)  | Author's Website |

Who Wants Free Money with Inhibitex?

February 02, 2012 | About:

Inhibitex (INHX) is being bought out by Bristol-Myers Squibb (NYSE:BMY) for $26 per share. You can elect to tender your shares now, to be effective on February 10. As I currently write this, shares trade at $25.52. That’s a 1.9% spread and you’ll be paid soon after the tender date. If you bought today and tender your shares, getting nearly 2% for about a two week holding period and extremely low risk is a pretty good deal. That’s a better way to make money than to follow these 2011 predictions.

This is an example where smaller investors who aren’t going to move the market can get make a good return with low risk. If you find a few of these each year, you’ll be in good shape. If you’re thinking about buying in and tendering your shares, read the filing here. There are a few things you need to know: The tender date may be extended, the percentage necessary to be tendered may not be met, the deal could fall apart due to the government or a legal ruling, and some negative info on its Hepatitis C drug could come out. I don’t think any of that will happen over the next ten days, but you should at least be aware of the risk.

I bought into Inhibitex a few weeks ago because I thought the spread was too great compared to the risk of the deal not going through. The spread at the time of my purchase was more than 7%. Considering the stock has traded between $2.15 and the $26 offer price, there is a good reason that there is a decent size spread. Plus, the company is dependent on one drug, so any bad news associated with it would be a serious problem. That’s why I made it a small position.

At this point, though, with eight days to go, that little bit of risk is now very close to zero. Don’t forget to factor in the short-term capital gains rate and any tender fees your custodian may charge.

Learn more at Intellectual Honesty.

Disclosure: Long INHX

About the author:


Rating: 3.9/5 (11 votes)

Comments

aashiq
Aashiq - 4 years ago


Steven,

I've read the TO and other 13 and 14Ds that have been proliferating on the SEC website. There is a lawsuit (not class action) and a request for an injunction against this tender - which will have a preliminary hearing on Monday, Feb 6th. What are your thoughts on the requested injunction?

Please leave your comment:


GuruFocus Mobile App Available


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK